Trimebutine
- Generic Name
- Trimebutine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H29NO5
- CAS Number
- 39133-31-8
- Unique Ingredient Identifier
- QZ1OJ92E5R
- Background
Trimebutine is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders . It is ...
- Indication
Indicated for symptomatic treatment of irritable bowel syndrome (IBS) and treatment of postoperative paralytic ileus following abdominal surgery.
- Associated Conditions
- Irritable Bowel Syndrome (IBS), Gastrointestinal spasms, Postoperative paralytic ileus
- Associated Therapies
- -
Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Universidad de Colima
- Target Recruit Count
- 82
- Registration Number
- NCT06268964
- Locations
- 🇲🇽
School of Medicine, University of Colima, Colima, Mexico
Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
- Conditions
- Interventions
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Hospital Britanico
- Target Recruit Count
- 80
- Registration Number
- NCT03359499
- Locations
- 🇦🇷
Hospital Britanico, Buenos Aires, Caba, Argentina
Effect of Topical Trimebutine on Pain After Hemorrhoidectomy
- Conditions
- Interventions
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 42
- Registration Number
- NCT03036111
- Locations
- 🇪🇬
Mansoura university hospital, Mansoura, Dakahlia, Egypt
Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole
- Conditions
- Interventions
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Xijing Hospital of Digestive Diseases
- Registration Number
- NCT02986685
- Locations
- 🇨🇳
Xijing Hosipital of Digestive Disease, Xi'an, Shaanxi, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.